In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA)-related rulings from around the country. The following rulings were reported on HISA's “rulings” portal ...

At present, there is no proposal to prohibit the manufacture, distribution and sale of Ranitidine, a medication used to reduce stomach acid, in the country, Minister of State for Health Anupriya ...

Any company manufacturing Ranitidine will face the same issue; the reason why the United States Food and Drug Administration (USFDA) and the European Medical Agency (EMA) stopped the sale of the ...

There is no link between the use of ranitidine, applied for treating and preventing gastric ulcers, and cancer, according to a recent study. Conducted in South Korea, the study, published in the ...

Experts at the US Federal Court state that links between the Ranitidine and cancer (which include lung, liver, and kidney cancer) are illegitimate.